MAIA Biotechnology, Inc.
MAIA
$1.30
$0.000.00%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 40.61% | -18.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 60.98% | -53.88% | |||
| Operating Income | -60.98% | 53.88% | |||
| Income Before Tax | -75.53% | 59.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -75.53% | 59.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -75.53% | 59.24% | |||
| EBIT | -60.98% | 53.88% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -44.36% | 63.61% | |||
| Normalized Basic EPS | -44.43% | 63.60% | |||
| EPS Diluted | -44.36% | 63.61% | |||
| Normalized Diluted EPS | -44.43% | 63.60% | |||
| Average Basic Shares Outstanding | 21.56% | 12.02% | |||
| Average Diluted Shares Outstanding | 21.56% | 12.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||